Central nervous system CNS lesions may occur 2 to 3 years after the onset of PAN and may lead to cognitive dysfunction, decreased alertness, seizures and neurologic deficits. Skin Skin abnormalities are very common in PAN and may include purpura, livedo reticularis, ulcers, nodules or gangrene. Skin involvement occurs most often on the legs and is very painful. Kidney Renal artery vasculitis may lead to protein in the urine, impaired kidney function, and hypertension.
|Published (Last):||3 April 2005|
|PDF File Size:||3.58 Mb|
|ePub File Size:||16.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Central nervous system CNS lesions may occur 2 to 3 years after the onset of PAN and may lead to cognitive dysfunction, decreased alertness, seizures and neurologic deficits. Skin Skin abnormalities are very common in PAN and may include purpura, livedo reticularis, ulcers, nodules or gangrene.
Skin involvement occurs most often on the legs and is very painful. Kidney Renal artery vasculitis may lead to protein in the urine, impaired kidney function, and hypertension.
Small percentage of patients go on to require dialysis. Gastrointestinal Tract Abdominal pain, gastrointestinal bleeding occasionally is mistaken for inflammatory bowel disease Hemorrhage, bowel infarction, and perforation are rare, but very serious Heart Clinical involvement of the heart does not usually cause symptoms.
However, some patients develop myocardial infarctions heart attacks or congestive heart failure. Eye Scleritis or inflammation in the sclera white part of the eye Genitals Testicular infarction What causes Polyarteritis Nodosa? Hepatitis B causes a minority of cases of PAN. With the availability of hepatitis B vaccine now, cases of PAN caused by hepatitis B are now rare in the developed world. It is possible that other infections contribute to other cases of PAN, but links between other infections and this disease remain conjectural at the present time.
How is Polyarteritis Nodosa Diagnosed? Routine laboratory tests may provide important clues to PAN, but there is no single blood test that is diagnostic of this disease. Proteinuria protein in the urine is common among those with kidney involvement. Nerve conduction studies are a non-invasive way of identifying nerves that are involved by the inflammation.
These nerves can then be biopsied to confirm the diagnosis. The diagnosis is confirmed by a biopsy showing pathologic changes in medium-sized arteries. The biopsy site may vary. Most biopsies are taken from skin, symptomatic nerve, or muscle. An angiogram of the abdominal blood vessels may also be very helpful in diagnosing PAN. Aneurysms most often affect the arteries leading to the kidneys, liver or gastrointestinal tract.
The criteria are designed to differentiate PAN from other forms of vasculitis. Not all patients have all criterion. Some, in fact, may have only 2 or 3 criteria, yet their physicians are still comfortable classifying their disease as PAN.
A committee of ACR physicians selected 10 disease features criteria as being those that best distinguish PAN from other vasculitides. In order to be classified as a PAN patient — for the purpose of research studies — a patient should have at least 3 of the 10 ACR criteria. Before the availability of effective therapy, untreated PAN was usually fatal within weeks to months.
Most deaths occurred as a result of kidney failure, heart or gastrointestinal complications. However, effective treatment is now available for PAN. After diagnosis, patients are treated with high doses of corticosteroids. Other immunosuppressive drugs are also added for patients who are especially ill. In most cases of PAN now, if diagnosed early enough the disease can be controlled, and often cured.
In medical terms, by David Hellmann, M. The American College of Physicians has given us permission to make this information available to patients contacting our Website. Polyarteritis nodosa is a small— and medium—sized arteritis affecting multiple organs, especially the skin, peripheral nerve, gut, kidney, and heart.
The age of onset ranges from childhood to late adulthood but averages 40 years. Polyarteritis nodosa has been associated with active hepatitis B, hepatitis C, or both; therefore, the disease is more common in injection drug users. Polyarteritis nodosa is probably mediated by deposition of immune complexes.
Evidence includes the observation that patients with polyarteritis nodosa associated with hepatitis B or hepatitis C have immune complexes consisting of immunoglobulin and viral antigens circulating in the blood and deposited in inflamed vessels. Moreover, antiviral therapy can remit the vasculitis in some of these patients. The onset is gradual over weeks to months, and the initial symptoms are often nonspecific. The earliest clues that the patient has vasculitis come usually from the skin where vasculitis may appear as palpable purpura, livedo reticularis, digital gangrene, or tender nodules , or the peripheral nervous system where infarction of one mixed motor and sensory nerve after another results in mononeuritis multiplex, one of the most specific clues that a patient has vasculitis.
Renal involvement eventually develops in most and is accompanied by hypertension in half of patients, whereas Granulomatosis with Polyangiitis rarely elevates the blood pressure. Polyarteritis nodosa also commonly involves the gut abdominal angina, hemorrhage, perforation , heart myocarditis, myocardial infarction , or eye scleritis. Rupture of renal or mesenteric micoaneurysms can simulate an acute abdomen. Confirming the diagnosis requires either biopsy specimen showing small— or medium—sized arteries, or mesenteric arteriography showing microaneurysms or alternating areas of stenosis and dilation.
Renal biopsy should be avoided unless angiography rules out microaneurysms susceptible to rupture. Without treatment, almost all affected patients die within 2 to 5 years.
However, newer studies suggest that prednisone alone may achieve the same high survival as prednisone and cyclophosphamide, although flares were less frequent in patients taking cyclophosphamide.
Other studies indicate that the traditional therapy with prednisone and cyclophosphamide should be abandoned in patients with polyarteritis nodosa associated with hepatitis B. Patients treated with the traditional combination respond, but almost all survivors become chronic carriers of hepatitis B and may die later of cirrhosis or variceal bleeding. The newly propsed regimen consists of 2 weeks of prednisone to control the vasculitis, followed by plasmapheresis to remove immune complexes, and accompanied by antiviral therapy with lamivudine to rid the patient of the hepatitis B infection.
The long—term value of anti—viral therapy for polyarteritis nodosa associated with hepatitis C is not established. Use of this Site All information contained within the Johns Hopkins Vasculitis website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site.
Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website. Primary Sidebar.
The cause remains unknown in the remaining cases; there may be causal and clinical distinctions between classic idiopathic PAN, the cutaneous forms of PAN, and PAN associated with chronic hepatitis. In polyarteritis nodosa, small aneurysms are strung like the beads of a rosary, therefore making "rosary sign" a diagnostic feature of the vasculitis. In polyarteritis nodosa, small aneurysms are strung like the beads of a rosary,  therefore making "rosary sign" an important diagnostic feature of the vasculitis. Nevertheless, their good discriminatory performances, indicated by the initial ACR analysis, suggested their potential usefulness for diagnostic purposes as well. Subsequent studies did not confirm their diagnostic utility, demonstrating a significant dependence of their discriminative abilities on the prevalence of the various vasculitides in the analyzed populations.